Quicker, More Accurate Evaluation For Cystic Fibrosis Patients Promised By New Test

Researchers at National Jewish Health have identified a simple gene-based blood test that more accurately and quickly measures cystic fibrosis patients’ response to therapy than current tests. The test, a measure of inflammatory gene expression, could improve patient care and help clear a backlog of promising medications now hung up in clinical trials.

More: continued here

Filed under: Cystic Fibrosis on October 28th, 2008